SGLT-2 inhibitors efficacy in type 2 diabetic patients with bariatric surgery

被引：0
|
作者：
Valderas, J. P. [1 ]
Preiss, Y. [2 ]
Sepulveda, M. [3 ]
Crovari, F. [4 ]
Boza, C. [5 ]
机构：
[1] Univ Antofagasta, Med Sci, Antofagasta, Chile
[2] Hosp Dipreca, Ctr Obes Treatment, Santiago, Chile
[3] Univ Diego Portales, Surg, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Surg, Santiago, Chile
[5] Clin Las Condes, Surg, Santiago, Chile
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
652
引用
收藏
页码：S316 / S317
页数：2
相关论文
共 50 条
  • [41] EFFECTS OF SGLT-2 INHIBITORS ON 24 H AMBP IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Wang, Qiongying
    Tian, Li
    Yu, Jing
    Bai, Feng
    JOURNAL OF HYPERTENSION, 2023, 41 : E466 - E466
  • [42] SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment
    Zhichao He
    Kakei Lam
    Wenxia Zhao
    Shan Yang
    Yu Li
    Jiayao Mo
    Siyuan Gao
    Dan Liang
    Kaifeng Qiu
    Min Huang
    Junyan Wu
    Acta Diabetologica, 2023, 60 : 401 - 411
  • [43] SGLT-2 inhibitors as second-line therapy in type 2 diabetes
    Tahrani, Abd A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 678 - 679
  • [44] Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions
    Ruggeri, Rosaria M.
    Grossrubatscher, Erika Maria
    Ciocca, Eleonora
    Hasballa, Iderina
    Jaafar, Simona
    Oldani, Monica
    Rubino, Manila
    Russo, Flaminia
    Isidori, Andrea M.
    Colao, Annamaria
    Faggiano, Antongiulio
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2025,
  • [45] SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes Comment
    Cheng, Alice Y. Y.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01): : 2 - 3
  • [46] Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery
    Sharma, Mitesh
    Nayar, Rahul
    Graham, Yitka
    Parretti, Helen M.
    Abbott, Sally
    Tahrani, Abd
    Miras, Alexander D.
    Madhok, Brijesh
    Singhal, Rishi
    Mahawar, Kamal
    OBESITY SURGERY, 2022, 32 (07) : 2469 - 2470
  • [47] Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery
    Mitesh Sharma
    Rahul Nayar
    Yitka Graham
    Helen M. Parretti
    Sally Abbott
    Abd Tahrani
    Alexander D. Miras
    Brijesh Madhok
    Rishi Singhal
    Kamal Mahawar
    Obesity Surgery, 2022, 32 : 2469 - 2470
  • [48] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [49] Effect of SGLT-2 Inhibitors on an impaired ventricular Repolarization Retrospective Study of Patients with Type 2 Diabetes
    Jecht, M.
    DIABETOLOGE, 2017, 13 (08): : 583 - 585
  • [50] The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure
    Demir, E.
    Kose, R.
    Pirmammadova, F.
    Unlugenc, H.
    Gurgun, C.
    Nalbantgil, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 219 - 220
12345